Stock IMP A SDB IMPLANTICA AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Implantica AG

Equities

IMP A SDB

SE0014855029

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:34 2024-05-31 am EDT 		5-day change 1st Jan Change
29.85 SEK +5.29% Intraday chart for Implantica AG +5.11% +24.90%
May. 15 Transcript : Implantica AG, Q1 2024 Earnings Call, May 15, 2024
May. 15 Implantica AG Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • Based on current prices, the company has particularly high valuation levels.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
IMPLANTICA AG Stock Implantica AG
+24.90% 802M -
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+75.69% 12.57B
B-
PENUMBRA, INC. Stock Penumbra, Inc.
-24.68% 7.34B
C+
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+12.58% 5.39B
D+
GETINGE AB Stock Getinge AB
-16.63% 4.84B
B
APT MEDICAL INC. Stock APT Medical Inc.
+26.90% 4.53B -
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.14% 3.91B
B-
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-22.99% 2.91B
C
NOVOCURE LIMITED Stock NovoCure Limited
+47.42% 2.37B
C-
SKAN GROUP AG Stock SKAN Group AG
-0.37% 2B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. IMP A SDB Stock
  4. Ratings Implantica AG